Fuji Pharma Co., Ltd.

TSE:4554.T

1559 (JPY) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 40,88935,42633,99033,79336,27937,90935,38734,22931,68029,21525,17421,522.06521,623.81219,701.95617,201.23614,940.538
Cost of Revenue 24,37420,86719,23918,92120,48321,95920,67120,69118,70916,83514,23312,203.97611,323.82210,622.5669,405.7838,471.393
Gross Profit 16,51514,55914,75114,87215,79615,95014,71613,53812,97112,38010,9419,318.08910,299.999,079.397,795.4536,469.145
Gross Profit Ratio 0.4040.4110.4340.440.4350.4210.4160.3960.4090.4240.4350.4330.4760.4610.4530.433
Reseach & Development Expenses 3,1842,4852,4463,0602,0521,7601,8251,8401,7291,7691,2801,303.7751,516.4071,114.446918.821625.544
General & Administrative Expenses 000000000001,037.2061,228.6561,137.9531,020.026931.096
Selling & Marketing Expenses 001,3451,4891,8881,8191,5371,2571,4061,1251,0381,030.805968.239723.44621.649431.005
SG&A 8,3317,3551,3451,4891,8881,8191,5371,2571,4061,1251,0382,068.0112,196.8951,861.3931,641.6751,362.101
Other Expenses 1,1428,2927,6077,1797,6789392718655224.261-2.9868.37811.17614.126
Operating Expenses 12,65710,77711,39811,72811,61811,55510,3979,9649,7159,2037,6755,823.0985,960.4955,142.1244,674.43,779.936
Operating Income 3,8583,7773,3493,1394,1734,3914,3143,5683,2513,1733,2613,494.9914,339.4953,937.2663,121.0532,689.209
Operating Income Ratio 0.0940.1070.0990.0930.1150.1160.1220.1040.1030.1090.130.1620.2010.20.1810.18
Total Other Income Expenses Net 541-5422-221-21281216-420-1465971-1,169.148-803.478-781.047-651.675-659.181
Income Before Tax 4,3993,7233,3712,9183,9614,4724,5303,1483,1053,2323,3322,325.8433,496.863,156.2192,469.3782,030.028
Income Before Tax Ratio 0.1080.1050.0990.0860.1090.1180.1280.0920.0980.1110.1320.1080.1620.160.1440.136
Income Tax Expense 9631,0269388329981,0991,2281,0291,0121,1531,264954.9121,292.0141,212.147943.42778.314
Net Income 3,4352,6962,4322,0852,9623,3723,3012,1182,0922,0782,0681,370.932,204.8461,944.0711,525.9581,251.714
Net Income Ratio 0.0840.0760.0720.0620.0820.0890.0930.0620.0660.0710.0820.0640.1020.0990.0890.084
EPS 141.35110.9890.5266.9297.02112.67110.3270.8268.7870.2773.2448.5583.8275.5359.2948.63
EPS Diluted 141.35110.9890.5266.9297.02112.67110.3270.8268.7870.2773.2448.5583.8275.5359.2948.63
EBITDA 7,5436,5235,4555,1976,3036,6426,3385,4905,3324,8274,6753,542.2164,523.1324,974.9623,422.2723,515.96
EBITDA Ratio 0.1840.1930.1590.150.1720.1780.1890.1520.1650.1680.1920.2170.2470.2530.2380.235